Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

97.70
Delayed Data
As of May 26
 -0.80 / -0.81%
Today’s Change
96.18
Today|||52-Week Range
157.02
-20.15%
Year-to-Date
The Good, the Bad and the Ugly; Explaining the Inexplicable: Doug Kass' Views
May 29 / TheStreet.com - Paid Partner Content
Alexion Shares Drop Amid Executive Changes
May 23 / TheStreet.com - Paid Partner Content
Analysts' Actions -- Kellogg, Kraft Heinz, Altria, PayPal and More
May 25 / TheStreet.com - Paid Partner Content
Here's Why Alexion Pharma (ALXN) Stock is Sinking Today
May 23 / Zacks.com - Paid Partner Content
Company News for May 24, 2017
May 24 / Zacks.com - Paid Partner Content
BMO: Too Early to Tell If Alexion's Management Shakeup Bodes Well for Stock
May 23 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data
May 24 / Zacks.com - Paid Partner Content
Biotech Movers: Cerus, Alexion, NantKwest
May 23 / TheStreet.com - Paid Partner Content
Trader's Daily Notebook: As Long Weekend Nears, Volume Will Stay Low
May 24 / TheStreet.com - Paid Partner Content
Alexion's (ALXN) Strensiq Results Positive in Long-Term Study
May 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close98.50
Today’s open98.77
Day’s range96.18 - 99.44
Volume6,660,773
Average volume (3 months)2,376,729
Market cap$21.9B
Dividend yield--
Data as of 4:00pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+14.91%
Earnings growth (next 5 years)+26.15%
Revenue growth (last year)+21.11%
P/E ratio46.5
Price/Sales9.22
Price/Book2.52

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.11-0.28%
INCYIncyte Corp-4.03-2.91%
BMRNBiomarin Pharmaceuti...+0.67+0.77%
VRTXVertex Pharmaceutica...+1.32+1.11%
Data as of 4:14pm ET, 05/26/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts